A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, ...

Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...

England's NHS pioneers a revolutionary blood test for faster cancer diagnosis and treatment. This 'liquid biopsy' detects ...

Researchers have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS ...

CHICAGO -- Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

As with all products, we will keep its safety under close review The Medicines and Healthcare products Regulatory Agency ...

The NHS is the world’s first health service to adopt a ‘blood test-first’ approach for diagnosing lung cancer.

People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid ...

Genetic testing for hereditary cancer unexpectedly uncovered a case of myelodysplastic syndrome (MDS), highlighting the need ...